Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
The most jam-packed earnings week for the quarter lies ahead, led by these two market bellwethers | marketwatch.com • |
5 Of The Highest Yielding Blue Chip Stocks To Buy Now | 247wallst.com • |
3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall Street | fool.com • |
Pfizer (NYSE:PFE) Shares Up 0.3% | news.google.com • |
How to Take Advantage of moves in (PFE) | news.google.com • |
Pfizer (NYSE:PFE) Sets New 12-Month Low at $25.20 | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-01 | 2024-03 | 0.56 | N/A | N/A | N/A |
2024-01-30 | 2023-12 | -0.19 | 0.1 | 0.29 | 152.63% |
2023-10-31 | 2023-09 | -0.32 | -0.17 | 0.15 | 46.88% |
2023-08-01 | 2023-06 | 0.56 | 0.67 | 0.11 | 19.64% |
2023-05-02 | 2023-03 | 1 | 1.23 | 0.23 | 23.00% |
2023-01-31 | 2022-12 | 1.03 | 1.14 | 0.11 | 10.68% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-10-16 | Wells Fargo | Upgrade | Equal-Weight | Equal-Weight |
2023-10-16 | Morgan Stanley | Upgrade | Equal-Weight | Equal-Weight |
2023-10-16 | Truist Securities | Upgrade | Buy | Buy |
2023-10-15 | Jefferies | Upgrade | Hold | Buy |
2023-10-15 | Wells Fargo | Upgrade | Equal-Weight | Equal-Weight |
2023-10-15 | JP Morgan | Upgrade | Neutral | Neutral |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-02-27 | BOSHOFF CHRISTOFFEL | Officer | 156.63K | Stock Award(Grant) |
2024-02-22 | BOURLA ALBERT | Chief Executive Officer | 332.49K | Conversion of Exercise of derivative security |
2024-02-26 | DAMICO JENNIFER B. | Officer | 13.50K | Stock Award(Grant) |
2024-02-26 | DE GERMAY ALEXANDRE | Officer | 74.38K | Stock Award(Grant) |
2023-12-14 | GOTTLIEB SCOTT | Director | 9.00K | Purchase |
2024-02-22 | JOHNSON RADY A | Officer | 103.45K | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 508.09M | 18.64B | 9.00% |
2023-06-29 | Blackrock Inc. | 445.15M | 16.33B | 7.88% |
2023-06-29 | State Street Corporation | 287.20M | 10.53B | 5.09% |
2023-06-29 | Wellington Management Group, LLP | 233.11M | 8.55B | 4.13% |
2023-06-29 | Capital World Investors | 199.01M | 7.30B | 3.52% |
2023-06-29 | Geode Capital Management, LLC | 112.87M | 4.14B | 2.00% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 176.05M | 6.46B | 3.12% |
2023-06-29 | Vanguard 500 Index Fund | 134.41M | 4.93B | 2.38% |
2023-05-30 | Fidelity 500 Index Fund | 62.81M | 2.39B | 1.11% |
2023-08-30 | SPDR S&P 500 ETF Trust | 62.20M | 2.20B | 1.10% |
2023-07-30 | Vanguard Specialized-Health Care Fund | 58.87M | 2.12B | 1.04% |
2023-08-30 | iShares Core S&P 500 ETF | 52.80M | 1.87B | 0.94% |
Dividend | Date |
---|---|
0.42 | 2024-05-09 |
0.42 | 2024-01-26 |
0.42 | 2024-01-25 |
0.41 | 2023-11-10 |
0.41 | 2023-11-09 |
0.41 | 2023-07-27 |
Split | Date |
---|---|
1054 : 1000 | 2020-11-17 |
3 : 1 | 1999-07-01 |
2 : 1 | 1997-07-01 |
2 : 1 | 1995-07-03 |
2 : 1 | 1991-04-01 |
2 : 1 | 1983-07-01 |
-
Pfe is sitting on a golden egg,fast track approval,starting mfg two billion investment someone knows some serious news
-
How is it possible that pfe is being traded on Saturday
-
How is it possible that pfe is being traded on Saturday
-
CEO interview for vaccine by October
-
CEO just set bar to have PFE to have COVID-19 vaccine by fall
-
Today 5am: BERLIN—The German biotech firm that has partnered with Pfizer Inc. to develop a coronavirus vaccine is confident it will be ready to seek regulatory approval by the end of the year, according to its chief executive.
Several hundred million doses could be produced even before approval, and over 1 billion by the end of 2021.
-
We will see a steady nice climb !
-
We are in a nice strong and steady climb!
-
Pfizer Reports Encouarging Data From Coronavirus Program
July 2, 2020, 11:05 AM EDT
Pfizer Inc. PFE and its Germany-based biotech partner BioNTech SE BNTX announced encouraging preliminiary results from its early-stage coronavirus program. Their nucleoside-modified messenger RNA (modRNA) vaccine candidate, BNT162b1, generated signnifcantly higher receptor binding domain ("RBD") IgG antibodies and SARS-CoV-2 neutralizing antibodies compared to sera of convalescent patients who have recovered from COVID-19. -
Patience....
-
Pfizer News: PFE Stock Surges 4% on Positive Covid-19 Vaccine Results
PFE is planning for further clinical trials
By William White, InvestorPlace Writer Jul 1, 2020, 3:25 pm EDT
Pfizer (NYSE:PFE) news for Wednesday concerning one of its vaccines for the novel coronavirus has PFE stock taking off. -
My brother in-laws in Germany said there’s excellent news in this joint partnership coming out!
-
-
Big shout out to whoever bought my 50 calls at open....i will gladly buy them back now.
-
lol this is so oversold.
-
Literally, selling a known blue chip biotech company, during a pandemic, while they are working on a vaccine and should have news within a few weeks, might be the dumbest thing I have ever seen. Either way, thanks for the cheap calls.
-
Bought early July calls. If this is not a discount, I dunno what is.
-
You people saying this will but 30-32 are absolutely delusional lol. Look at the size of the orders coming in at 36 and you will realize it will not go much lower than that....shorts are screwed next week.
-
$PFE Just a friendly reminder that Pfizer manufactures Viagra and Xanax amongst many others. Big opportunity to buy rn.
-
Woah anyone know what’s happening
-
5 Of The Highest Yielding Blue Chip Stocks To Buy Now
247wallst.com • -
Pfizer (NYSE:PFE) Shares Up 0.3%
news.google.com • -
How to Take Advantage of moves in (PFE)
news.google.com • -
Pfizer (NYSE:PFE) Sets New 12-Month Low at $25.20
news.google.com • -
7 Dividend Stocks to Buy Now for Steady Returns in Any Market
investorplace.com • -
Pfizer (NYSE:PFE) Notches Up on New FDA Approval
news.google.com • -
Pfizer (NYSE:PFE) Hits New 52-Week Low at $25.20
news.google.com • -
Pfizer Stock: Pharma Giant Takes On Hemgenix At $3.5 Million A Dose
news.google.com • -
What Factors Will Drive Pfizer's Q1 Performance?
forbes.com • -
What Factors Will Drive Pfizer's Q1 Performance?
news.google.com • -
Pfizer (NYSE:PFE) Notches Up on New FDA Approval- TipRanks
news.google.com • -
June 7th Options Now Available For Pfizer (PFE)
news.google.com • -
What's Going On With Pfizer Stock On Thursday?- Benzinga
news.google.com • -
3 Bargain Stocks Near 52-week Lows
marketbeat.com • -
Bristol Myers posts quarterly loss, revenue rises 5%
news.google.com • -
Pfizer Declares Second-Quarter 2024 Dividend
news.google.com • -
Pfizer (PFE), BioNTech Seek Full Approval for COVID Jab Booster
news.google.com • -
The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth
news.google.com • -
The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth
investorplace.com • -
3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge
investorplace.com • -
Better Buy: Pfizer vs. Viking Therapeutics
fool.com • -
Pfizer (PFE) Rises Higher Than Market: Key Facts
zacks.com • -
3 Blue-Chip Stocks That Will Beat Index Returns Over the Next 3 Years
investorplace.com • -
Unveiling Pfizer's Potent Cocktail: Key Drivers Of Free Cash Flow Growth
seekingalpha.com • -
Boost Your Dividend Income With These Two High-Yield Stocks
seekingalpha.com • -
The 3 Most Overlooked Stocks Set for a Triple-Digit Comeback
investorplace.com • -
Buy 11 MediaMade April ProActive Dividend Dogs
seekingalpha.com • -
Pfizer's Doldrums, Just A Bad Case Of COVID-19?
seekingalpha.com • -
Is Pfizer Stock a Buy?
fool.com • -
Pfizer's Innovative Drug Pipeline Provides Ample Reason To Buy It Here
seekingalpha.com • -
Pfizer: The Market Is Wrong
seekingalpha.com • -
7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape
investorplace.com • -
Where Will Pfizer Stock Be in 10 Years?
fool.com • -
Pfizer Stock Rises on Upbeat RSV Vaccine Trial Data
schaeffersresearch.com • -
3 Dirt-Cheap Stocks That Could Make You Filthy Rich
investorplace.com • -
Is Trending Stock Pfizer Inc. (PFE) a Buy Now?
zacks.com • -
The 3 Most Undervalued Biotech Stocks to Buy in April 2024
investorplace.com • -
Final Trades: Pfizer, Alphabet and Amazon
youtube.com • -
2 Strong Dividend Buys And 2 Sells For Q2 2024
seekingalpha.com • -
Unbeatable Blue Chips: 7 Must-Own Stocks for Every Portfolio
investorplace.com • -
Blue-Chip Bulldozers: 7 Stock Giants to Plow Through a Wall of Worries
investorplace.com • -
4 Dividend Aristocrats Trading at a Discount
marketbeat.com • -
Better Recovery Story Buy: Pfizer vs Moderna
fool.com • -
5 Very Large Cap Blue Chip Stocks With 5% and Higher Dividends
247wallst.com • -
7 Dividend Stocks to Secure Your Financial Freedom by 2026
investorplace.com • -
Final Trades: IBIT, ULTA, LNC & PFE
youtube.com • -
5 Absolutely Best Dividend Stocks Yielding Over 5%
247wallst.com • -
The 2025 Double: 3 Stocks Poised to Deliver 100% Gains in Just 12 Months
investorplace.com • -
Harnessing AI for Drug Discovery: Top 3 Stocks to Watch
investorplace.com • -
One AI/Healthcare Stock to Buy Today
investorplace.com • -
Buffett's Backdoor Buys: 3 Stocks His Secret Portfolio Is Quietly Accumulating
investorplace.com • -
7 Stocks That Will Make Your Friends Green with Envy
investorplace.com • -
7 High-Value Stocks With Massive Wealth-Building Potential
investorplace.com • -
Is Pfizer the Best Dividend Stock for You?
fool.com • -
3 Juicy Stocks Serving Up 5% Dividends That You Can Snag for $50
investorplace.com •